Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 141

1.

Ethical challenges in tracheostomy-assisted ventilation in amyotrophic lateral sclerosis.

Magelssen M, Holmøy T, Horn MA, Fondenæs OA, Dybwik K, Førde R.

J Neurol. 2018 Sep 14. doi: 10.1007/s00415-018-9054-x. [Epub ahead of print]

PMID:
30218178
2.

Serum levels of leptin and adiponectin are not associated with disease activity or treatment response in multiple sclerosis.

Kvistad SS, Myhr KM, Holmøy T, Benth JŠ, Wergeland S, Beiske AG, Bjerve KS, Hovdal H, Midgard R, Sagen JV, Torkildsen Ø.

J Neuroimmunol. 2018 Oct 15;323:73-77. doi: 10.1016/j.jneuroim.2018.07.011. Epub 2018 Jul 24.

PMID:
30196837
3.

Genetic testing in amyotrophic lateral sclerosis.

Nakken O, Sørum L, Holmøy T.

Tidsskr Nor Laegeforen. 2018 Sep 3;138(13). doi: 10.4045/tidsskr.18.0193. Print 2018 Sep 4. Norwegian, English.

4.

Extensive Multiple Sclerosis Reactivation after Switching from Fingolimod to Rituximab.

Holmøy T, Torkildsen Ø, Zarnovicky S.

Case Rep Neurol Med. 2018 Jul 19;2018:5190794. doi: 10.1155/2018/5190794. eCollection 2018.

5.

α-Linolenic acid is associated with MRI activity in a prospective cohort of multiple sclerosis patients.

Bjornevik K, Myhr KM, Beiske A, Bjerve KS, Holmøy T, Hovdal H, Midgard R, Riise T, Wergeland S, Torkildsen Ø.

Mult Scler. 2018 May 1:1352458518779925. doi: 10.1177/1352458518779925. [Epub ahead of print]

PMID:
29862891
6.

Sex ratio in multiple sclerosis mortality over 65 years; an age-period-cohort analysis in Norway.

Nakken O, Lindstrøm JC, Holmøy T.

J Neurol. 2018 Jun;265(6):1295-1302. doi: 10.1007/s00415-018-8832-9. Epub 2018 Mar 21.

PMID:
29564602
7.

Severe multiple sclerosis reactivation after gonadotropin treatment.

Torkildsen Ø, Holmøy T, Myhr KM.

Mult Scler Relat Disord. 2018 May;22:38-40. doi: 10.1016/j.msard.2018.02.031. Epub 2018 Mar 6.

PMID:
29525298
8.

Assessing amyotrophic lateral sclerosis prevalence in Norway from 2009 to 2015 from compulsory nationwide health registers.

Nakken O, Lindstrøm JC, Tysnes OB, Holmøy T.

Amyotroph Lateral Scler Frontotemporal Degener. 2018 May;19(3-4):303-310. doi: 10.1080/21678421.2017.1418004. Epub 2017 Dec 22.

PMID:
29271248
9.

Selective intrathecal enrichment of G1m1-positive B cells in multiple sclerosis.

Lossius A, Tomescu-Baciu A, Holmøy T, Vedeler CA, Røsjø E, Lorentzen ÅR, Casetta I, Vartdal F.

Ann Clin Transl Neurol. 2017 Sep 27;4(10):756-761. doi: 10.1002/acn3.451. eCollection 2017 Oct.

10.

In Silico Prediction Analysis of Idiotope-Driven T-B Cell Collaboration in Multiple Sclerosis.

Høglund RA, Lossius A, Johansen JN, Homan J, Benth JŠ, Robins H, Bogen B, Bremel RD, Holmøy T.

Front Immunol. 2017 Oct 2;8:1255. doi: 10.3389/fimmu.2017.01255. eCollection 2017.

11.

July 2017 ENCALS statement on edaravone.

Al-Chalabi A, Andersen PM, Chandran S, Chio A, Corcia P, Couratier P, Danielsson O, de Carvalho M, Desnuelle C, Grehl T, Grosskreutz J, Holmøy T, Ingre C, Karlsborg M, Kleveland G, Koch JC, Koritnik B, KuzmaKozakiewicz M, Laaksovirta H, Ludolph A, McDermott C, Meyer T, Mitre Ropero B, Mora Pardina J, Nygren I, Petri S, Povedano Panades M, Salachas F, Shaw P, Silani V, Staaf G, Svenstrup K, Talbot K, Tysnes OB, Van Damme P, van der Kooi A, Weber M, Weydt P, Wolf J, Hardiman O, van den Berg LH.

Amyotroph Lateral Scler Frontotemporal Degener. 2017 Nov;18(7-8):471-474. doi: 10.1080/21678421.2017.1369125. Epub 2017 Oct 4. Review. No abstract available.

12.

An update on cladribine for relapsing-remitting multiple sclerosis.

Holmøy T, Torkildsen Ø, Myhr KM.

Expert Opin Pharmacother. 2017 Oct;18(15):1627-1635. doi: 10.1080/14656566.2017.1372747. Epub 2017 Sep 11. Review.

PMID:
28858531
13.

Listeria monocytogenes infection associated with alemtuzumab - - a case for better preventive strategies.

Holmøy T, von der Lippe H, Leegaard TM.

BMC Neurol. 2017 Apr 4;17(1):65. doi: 10.1186/s12883-017-0848-8.

14.

High dose vitamin D supplementation does not affect biochemical bone markers in multiple sclerosis - a randomized controlled trial.

Holmøy T, Lindstrøm JC, Eriksen EF, Steffensen LH, Kampman MT.

BMC Neurol. 2017 Apr 4;17(1):67. doi: 10.1186/s12883-017-0851-0.

15.

Re: Familieplanlegging, graviditet og amming ved multippel sklerose.

Holmøy T, Torkildsen Ø.

Tidsskr Nor Laegeforen. 2017 Feb 21;137(4):259. doi: 10.4045/tidsskr.17.0054. eCollection 2017 Feb. Norwegian. No abstract available.

PMID:
28225223
Free Article
16.

Sequence variations in C9orf72 downstream of the hexanucleotide repeat region and its effect on repeat-primed PCR interpretation: a large multinational screening study.

Nordin A, Akimoto C, Wuolikainen A, Alstermark H, Forsberg K, Baumann P, Pinto S, de Carvalho M, Hübers A, Nordin F, Ludolph AC, Weishaupt JH, Meyer T, Grehl T, Schweikert K, Weber M, Burkhardt C, Neuwirth C, Holmøy T, Morita M, Tysnes OB, Benatar M, Wuu J, Lange DJ, Bisgård C, Asgari N, Tarvainen I, Brännström T, Andersen PM.

Amyotroph Lateral Scler Frontotemporal Degener. 2017 May;18(3-4):256-264. doi: 10.1080/21678421.2016.1262423. Epub 2016 Dec 12.

PMID:
27936955
17.
18.

Family planning, pregnancy and breastfeeding in multiple sclerosis.

Holmøy T, Torkildsen Ø.

Tidsskr Nor Laegeforen. 2016 Nov 8;136(20):1726-1729. eCollection 2016 Nov. Review. English, Norwegian.

19.
20.

Negative interaction between smoking and EBV in the risk of multiple sclerosis: The EnvIMS study.

Bjørnevik K, Riise T, Bostrom I, Casetta I, Cortese M, Granieri E, Holmøy T, Kampman MT, Landtblom AM, Magalhaes S, Pugliatti M, Wolfson C, Myhr KM.

Mult Scler. 2017 Jun;23(7):1018-1024. doi: 10.1177/1352458516671028. Epub 2016 Sep 23.

PMID:
27663872

Supplemental Content

Loading ...
Support Center